Implications from Under-reporting at Lifetime, Death Certificate Notifications and Trace-back on the Recorded Incidence of a “Newly” Established Population-based Cancer Registry^[*]

Summary

Objectives: Population-based cancer registries (CRs) are powerful tools for measuring cancer burden and progress against cancer. The study’s objective was to investigate the effects of under-reporting at lifetime, death certificate notifications, and trace-back on the incidence a newly established population-based CR may record during its initial 15 years of operation.

Methods: Using cancer data of nine CRs of the SEER programme we performed model calculations to investigate temporal trends of the recorded incidence that might be expected if registration started in 1995 with gradually increasing proportions of cancers reported to the CR. It was assumed that the CR obtains all death certificates providing cancer as the underlying cause of death. Different scenarios with regard to the development of the pro -portions of cancers reported to the CR and the use of trace-back were evaluated.

Results: Our model calculations demonstrated that the inclusion of cancers notified from death certificates which were diagnosed prior to the start of registration and which attribute to the incidence estimates of the year of death (‘prevalent’ cases) may compensate under-reporting typically observed right after the start of a CR. The re corded incidence may even be overestimated during the first years of registration, if large amounts of prevalent cancers are notified from death certificates (e.g. overestimation of lung cancer incidence by 8% and 21% in the first year of registration, if the proportions of cases reported were 50% and 70% in that year, overestimation of myeloma incidence still exceeding 5% after eight years of registration, if the proportion of cases reported to the CR had reached 97.5% after six years). Trace-back may effectively reduce the recorded surplus cancer cases.

Conclusions: During the initial years of registration, the inclusion of prevalent cancers from death certificates may compensate the higher amount of underreporting right after the start of a CR. Accurate incidence estimates may nevertheless be observed for highly fatal cancers if substantial proportions of cancer cases are missed at lifetime, however apparent incidence trends observed in the initial years of registration need to be interpreted with caution.

Keywords

Population-based - cancer - registries - incidence - under-reporting - death certificates - trace-back - model calculations

^* Supplementary online material published on our website http://dx.doi.org/10.3414/ME15-01-0004

• References

• 1 Brenner H, Hakulinen T. Implications of incomplete registration of deaths on long-term survival estimates from population-based cancer registries. Int J Cancer 2009; 125 (Suppl. 02) 432-437.
• 2 Brenner H, Hakulinen T. Population-based monitoring of cancer patient survival in situations with imperfect completeness of cancer registration. Br J Cancer 2005; 92 (Suppl. 03) 576-579.
• 3 Bray F, Parkin DM. Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness. Eur J Cancer 2009; 45 (Suppl. 05) 747-755.
• 4 Parkin DM, Bray F. Evaluation of data quality in the cancer registry: principles and methods Part II Completeness. Eur J Cancer 2009; 45 (Suppl. 05) 756-764.
• 5 Powell J. Data sources and reporting. In: Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG. editors. Cancer registration: principles and methods. IARC scientific publications Nr 95. Lyon: International Agency for Research on Cancer; 1991. pp 29-42.
• 6 Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M. et al., editors. Cancer Incidence in Five Continents. Volume IX IARC Scientific Publications No. 160. Lyon: International Agency for Research on Cancer; 2007
• 7 World Health Organization.. Medical certification of cause of death: instructions for physicians on use of international form of medical certificate of cause of death. Geneva: World Health Organization; 1979
• 8 Parkin DM, Hakulinen T. Analysis of Survival. In: Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG. editors. Cancer registration: principles and methods. IARC Scientific Publications No. 95. Lyon: International Agency for Research on Cancer; 1991. pp 159-176.
• 9 Brenner H, Jansen L. Determinants and interpretation of death certificate only proportions in the initial years of newly established cancer registries. Eur J Cancer 2012; 49 (Suppl. 04) 931-937.
• 10 Surveillance, Epidemiology, and End Results (SEER) Program. ( http://www.seer.cancer.gov ). Research Data 1973–2010 (released April 2013, based on the November 2012 submission). Bethesda MD: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; 2013
• 11 Harlan LC, Hankey BF. The surveillance, epidemiology, and end-results program database as a resource for conducting descriptive epidemiologic and clinical studies. J Clin Oncol 2003; 21 (Suppl. 12) 2232-2233.
• 12 Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF. et al. SEER Cancer Statistics Review, 1975–2010 (based on November 2012 SEER data submission, posted to the SEER web site). Bethesda, MD: National Cancer Institute; 2013
• 13 Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 1961; 6: 101-121.
• 14 Henson DE, Ries LA. The relative survival rate. Cancer 1995; 76 (Suppl. 10) 1687-1688.
• 15 Holleczek B, Brenner H. Reduction of population-based cancer survival estimates by trace back of death certificate notifications: an empirical illustration. Eur J Cancer 2011; 48 (Suppl. 06) 797-804.
• 16 Percy C, Dolman A. Comparison of the coding of death certificates related to cancer in seven countries. Public Health Rep 1978; 93 (Suppl. 04) 335-350.
• 17 Percy C, Stanek E, Gloeckler L. Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Public Health 1981; 71 (Suppl. 03) 242-250.
• 18 Gemeinsames Krebsregister der Länder Berlin, Brandenburg, Mecklenburg-Vorpommern, Sachsen-Anhalt und der Freistaaten Sachsen und Thüringen.. Vollzähligkeit von Todesinformationen im GKR. Berlin: Gemeinsames Krebsregisterr der Länder Berlin, Brandenburg, Mecklenburg-Vorpommern, Sachsen-Anhalt und der Freistaaten Sachsen und Thüringen; 2008
• 19 Bertz J, Giersiepen K, Haberland J, Hentschel S, Kaatsch P, Katalinic A. et al. Cancer in Germany. Fifth revised, updated edition. Saarbrücken: Association of Population-Based Cancer Registries in Germany in cooperation with the Robert Koch Institute; 2006
• 20 Haberland J, Schön D, Bertz J, Görsch B. Vollzähligkeitsschätzungen von Krebsregisterdaten in Deutschland. Bundesgesundheitsbl – Gesundheitsforsch – Gesundheitsschutz 2003; 46: 770-774.
• 21 Robert Koch Institute, Association of Population-based Cancer Registries in Germany, editors.. Cancer in Germany 2003–2004. Incidence and Trends. Sixth edition. Berlin: Robert Koch Institute; 2008
• 22 Robert Koch Institute, Association of Population-based Cancer Registries in Germany, editors.. Cancer in Germany 2005/2006. Incidence and Trends. Seventh edition. Berlin: Robert Koch Institute; 2010
• 23 Robert Koch Institute, Association of Population-based Cancer Registries in Germany, editors.. Cancer in Germany 2007/2008. Incidence and Trends. Eighth edition. Berlin: Robert Koch Institute; 2012
• 24 Robert Koch Institute, Association of Population-based Cancer Registries in Germany, editors.. Cancer in Germany 2009/2010. Ninth edition. Berlin: Robert Koch Institute; 2014
• 25 MacLennan R. Items of patient information which may be collected by registries. In: Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG. editors. Cancer registration: principles and methods. IARC Scientific Publications No. 95. Lyon: International Agency for Research on Cancer; 1991. pp 43-63.
• 26 Navarro C, Martos C, Ardanaz E, Galceran J, Izarzugaza I, Peris-Bonet R. et al. Population-based cancer registries in Spain and their role in cancer control. Annals of oncology : official journal of the European Society for Medical Oncology/ESMO 2010; 21 (Suppl. 03) iii3-13.
• 27 Silcocks P. Survival of death certificate initiated registrations: Selection bias, incomplete trace-back or higher mortality?. Br J Cancer 2006; 95 (Suppl. 11) 1576-1578.